Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study-Reference-Cited by-同舟云学术

Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study

Published:2017 Issue:5 Volume:28 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Sun Pengming¹²^ORCID,Song Yiyi²,Ruan Guanyu¹^ORCID,Mao Xiaodan¹^ORCID,Kang Yafang¹^ORCID,Dong Binhua¹^ORCID,Lin Fen¹

Affiliation:

1. Laboratory of Gynecologic Oncology, Fujian Provincial Maternity & Children's Health Hospital of Fujian Medical University, Fuzhou, China.

2. Department of Gynecology, Fujian Provincial Maternity & Children's Health Hospital of Fujian Medical University, Fuzhou, China.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2017.28.e50

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The significance of extensive HPV genotyping for cervical high-grade neoplasia among women with atypical glandular cells;American Journal of Clinical Pathology;2024-08-07

2. Assessment of Efficacy and Accuracy of Cervical Cytology Screening With Artificial Intelligence Assistive System;Modern Pathology;2024-06

3. Single and Multiple High-Risk Human Papillomavirus Infections in Histopathologically Confirmed Cervical Squamous Lesions: Incidences, Distribution, and Associated Detection Rates for Precancerous and Cancerous Lesions;Laboratory Investigation;2023-11

4. Risk of cervical intraepithelial neoplasia grade 3 or more diagnoses for human papillomavirus16/18-positive women by cytology and co-infection status;Infectious Agents and Cancer;2023-10-09

5. Platelet-to-Lymphocyte Ratio (PLR) as the Prognostic Factor for Recurrence/Residual Disease in HSIL Patients After LEEP;Journal of Inflammation Research;2023-05